BMC Cancer

Papers
(The TQCC of BMC Cancer is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Clinical effects of curcumin in enhancing cancer therapy: A systematic review184
Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis108
Gut microbiome and its role in colorectal cancer103
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protoc82
Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review80
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis78
Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review77
Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis74
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial73
Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program71
Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model68
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma68
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma67
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients66
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)66
Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling65
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma64
Association between heavy metals and colon cancer: an ecological study based on geographical information systems in North-Eastern Iran63
Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis62
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer61
Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up60
Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis59
PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial58
Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis57
Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases57
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis57
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis57
LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target55
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells54
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer50
Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody50
Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis49
Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis49
Prognosis of pregnancy-associated breast cancer: a meta-analysis49
Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer49
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 201948
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review48
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study47
Fusobacterium nucleatum and oral cancer: a critical review47
A convolutional neural network-based system to classify patients using FDG PET/CT examinations46
Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression46
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma45
Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon45
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma44
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications44
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results44
Tumor mutational burden is associated with poor outcomes in diffuse glioma44
Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status44
Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a con43
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)43
Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma43
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study42
Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer42
Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews41
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma41
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a p40
Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy40
INHBA is a prognostic predictor for patients with colon adenocarcinoma40
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer40
Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database40
A scientometric analysis of neuroblastoma research40
Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-40
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)39
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population39
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer38
PTEN loss correlates with T cell exclusion across human cancers38
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years38
The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma38
Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis38
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma38
Limb salvage versus amputation in patients with osteosarcoma of the extremities: an update in the modern era using the National Cancer Database38
Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis37
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient37
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma37
Designing an exercise intervention for adult survivors of childhood cancers37
Development and validation of a five-immune gene prognostic risk model in colon cancer37
A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery37
A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)37
Identification of immune cells and mRNA associated with prognosis of gastric cancer36
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review36
Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing36
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous reco36
CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer35
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer35
Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea35
The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophagea35
Homologous recombination proficiency in ovarian and breast cancer patients34
The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis34
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screeni34
Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study34
Nutritional status according to the mini nutritional assessment (MNA)® as potential prognostic factor for health and treatment outcomes in patients with cancer – a systematic review34
Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis33
A novel pancreatic tumour and stellate cell 3D co-culture spheroid model33
LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis33
PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma33
ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors33
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study33
Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study32
Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis32
Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–201732
Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer32
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis32
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model32
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial32
Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis32
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma32
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients32
Elastin is a key factor of tumor development in colorectal cancer31
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)31
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) rando31
SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target31
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis31
Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma31
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer31
Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology31
Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients31
Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States31
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint 31
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer30
A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma30
Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PRE-HIIT): protocol for a randomized controlled trial30
Machine-learning based MRI radiomics models for early detection of radiation-induced brain injury in nasopharyngeal carcinoma30
Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study30
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma30
A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer30
The patient-level effect of the cost of Cancer care – financial burden in German Cancer patients29
Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 sta29
Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report29
Incidence and time trends of sarcoma (2000–2013): results from the French network of cancer registries (FRANCIM)29
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study29
Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis29
Risk and prognostic factors of breast cancer with liver metastases29
A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma29
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affe29
Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome29
Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells28
Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression28
Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study28
Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis28
Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients28
The mixed blessing of AMPK signaling in Cancer treatments28
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review28
Long-term trends in colorectal cancer: incidence, localization, and presentation27
Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer27
Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer27
Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers27
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer27
Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation27
lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC27
Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival27
Immune characterization of metastatic colorectal cancer patients post reovirus administration27
Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer27
The impact of high-intensity interval training exercise on breast cancer survivors: a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems27
Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway27
YB-1 transferred by gastric cancer exosomes promotes angiogenesis via enhancing the expression of angiogenic factors in vascular endothelial cells27
The psychosocial determinants of quality of life in breast cancer survivors: a scoping review27
Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence27
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients27
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study27
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response27
Pretreatment elevated prognostic nutritional index predicts a favorable prognosis in patients with prostate cancer27
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertroph27
Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice27
Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial26
Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach26
The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis26
Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study26
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis26
Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice25
Genetic alterations and their therapeutic implications in epithelial ovarian cancer25
High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia25
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial25
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells25
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell 25
Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma25
Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis25
Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer25
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label pha25
Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast25
Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma25
The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma25
Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma25
Current lung cancer screening guidelines may miss high-risk population: a real-world study25
The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review25
Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study25
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy25
A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 201925
Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients24
Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study24
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors24
Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer24
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma24
Supporting the patients with advanced cancer and their family caregivers: what are their palliative care needs?24
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours24
Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer24
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio tri24
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment24
Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients24
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis24
Anti-proliferative activity of A. Oxyphylla and its bioactive constituent nootkatone in colorectal cancer cells24
Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma24
A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates24
MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma24
Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck23
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway23
A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study23
Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway23
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma23
The benefits and acceptability of virtual reality interventions for women with metastatic breast cancer in their homes; a pilot randomised trial23
Independence of HIF1a and androgen signaling pathways in prostate cancer23
Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis23
CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy23
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma23
Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study23
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation23
Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis23
Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes22
Head and neck cancer patients’ preferences for individualized prognostic information: a focus group study22
Fibroadenoma versus phyllodes tumor: a vexing problem revisited!22
Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains22
Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer22
Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women22
MiR-16-5p suppresses breast cancer proliferation by targeting ANLN22
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma22
RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers22
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies22
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer22
Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect22
Cancer cases and deaths attributable to lifestyle risk factors in Chile22
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis22
Change in public awareness of colorectal cancer symptoms following the Be Cancer Alert Campaign in the multi-ethnic population of Malaysia22
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomiz22
Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis22
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma22
The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants22
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial22
Efficient mutation screening for cervical cancers from circulating tumor DNA in blood22
Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study22
Quality of life and psychological distress during cancer: a prospective observational study involving young breast cancer female patients22
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer22
AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality22
Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F122
The prognostic values of m6A RNA methylation regulators in uveal melanoma22
The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies22
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker22
CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A22
Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels22
Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer22
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 201922
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China21
0.04952597618103